Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association

Abstract

The diagnosis and management of hypertension, a common cardiovascular risk factor among the general population, have been based primarily on the measurement of blood pressure (BP) in the office. BP may differ considerably when measured in the office and when measured outside of the office setting, and higher out-of-office BP is associated with increased cardiovascular risk independent of office BP. Self-measured BP monitoring, the measurement of BP by an individual outside of the office at home, is a validated approach for out-of-office BP measurement. Several national and international hypertension guidelines endorse self-measured BP monitoring. Indications include the diagnosis of white-coat hypertension and masked hypertension and the identification of white-coat effect and masked uncontrolled hypertension. Other indications include confirming the diagnosis of resistant hypertension and detecting morning hypertension. Validated self-measured BP monitoring devices that use the oscillometric method are preferred, and a standardized BP measurement and monitoring protocol should be followed. Evidence from meta-analyses of randomized trials indicates that self-measured BP monitoring is associated with a reduction in BP and improved BP control, and the benefits of self-measured BP monitoring are greatest when done along with cointerventions. The addition of self-measured BP monitoring to office BP monitoring is cost-effective compared with office BP monitoring alone or usual care among individuals with high office BP. The use of self-measured BP monitoring is commonly reported by both individuals and providers. Therefore, self-measured BP monitoring has high potential for improving the diagnosis and management of hypertension in the United States. Randomized controlled trials examining the impact of self-measured BP monitoring on cardiovascular outcomes are needed. To adequately address barriers to the implementation of self-measured BP monitoring, financial investment is needed in the following areas: improving education and training of individuals and providers, building health information technology capacity, incorporating self-measured BP readings into clinical performance measures, supporting cointerventions, and enhancing reimbursement.

The influence of healthcare financing on cardiovascular disease prevention in people living with HIV

“…Doing this and clearly and consistently communicating these expanded services to HIV providers, will provide PLWH the resources to obtain evidence-based prevention services (e.g. home blood pressure monitoring, targeted cholesterol medications, coronary calcium scoring) [ 25 ]. It may also incentivize HIV clinicians who provide primary care to appropriately assess and manage cardiovascular risk.…”

Early blood pressure assessment after acute myocardial infarction: Insights using digital health technology

“… 2 BP monitoring is one important component of management following AMI, and self-monitored BP have potential to improve the diagnosis and management of hypertension. 3 The 2011 American Heart Association/American College of Cardiology (AHA/ACC) secondary prevention guidelines for patients with atherosclerotic cardiovascular disease (CVD) emphasize BP control to <140 mmHg systolic and <90 mmHg diastolic. 2 The 2017 AHA/ACC Clinical Practice Guidelines for hypertension lowered the BP goal to <130 mmHg systolic and <80 mmHg diastolic, 4 , 5 The early post-discharge period is a particularly vulnerable time, in which patients transition from having inpatient vitals monitored multiple times a day with close titration of antihypertensives to outpatient care with fewer assessments of vitals and adjustment of antihypertensives.…”

A National Commitment to Improve the Care of Patients With Hypertension in the US

“…Achieving hypertension control rates of 70% and greater requires a team; a standardized treatment approach or protocol; a data system that provides accurate and timely insights into performance; and a set of strategies to support patients in self-monitoring their blood pressure and in adhering to medications and lifestyle recommendations. 3,4,8 A recent policy statement from the American Heart Association and the American Medical Association, 9 as well as current clinical practice guidelines, 10 recommend out-of-office or selfmeasured blood pressure monitoring (SMBP) along with support from the clinical team to help individuals achieve and maintain control, and to avoid the traps of "white coat" or "masked" hypertension. The rapid adoption and expansion of telehealth during the pandemic may accelerate the implementation of SMBP programs by practices and health systems across the country.…”

“…Improving access to validated devices, training patients in their use, setting up systems to receive and analyze patient-generated data, and returning timely treatment advice back to patients are steps that could gen-erate rapid returns in patient engagement and subsequently in hypertension control. 9 Rewarding clinical teams and health systems for excellence in hypertension control can take many forms. Whether through valuebased insurance design, quality awards, financial bonuses, or local or national recognition, these returns are essential in creating deep and enduring investments in hypertension control.…”